Close Menu

Ready to Revise?

When preparing revisions to an NIH grant application, DrugMonkey says "one of the best starting places … is to think about the review process." For example, an investigator who plans to revise and resubmit should consider that his or her grant will "in most cases … go back to the same study section," DrugMonkey says, and, as such, it will likely be reviewed by someone who has already seen it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.